Invitae Corp.

Invitae Corp.

Invitae Corp.

Overview
Date Founded

2010

Headquarters

1400 16th Street San Francisco CA 94103

Type of Company

Public

Employees (Worldwide)

2,100

Industries

Medical Support Services
Hospitals & Patient Services
Biotechnology

Company Description

Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA.

Contact Data
Trying to get in touch with decision makers at Invitae Corp.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Founder

Chief Financial Officer

Chief Operating Officer

Secretary & General Counsel

Chief Commercial Officer

Chief Medical Officer

Chief Digital Officer

Chief Accounting Officer

Environment, Social & Governance

Co-Founder

Board of Directors

Co-Founder at Invitae Corp.

Partner at Aisling Capital

Chief Financial Officer/Operations Executive at Zymergen, Inc.

Chief Operating Officer at Funding Circle USA, Inc.

Chief Technology Officer at 1Life Healthcare, Inc.

Chief Executive Officer at Candela Corp.

Chief Executive Officer at Genapsys

Paths to Invitae Corp.
Potential Connections via
Relationship Science
You
Invitae Corp.
Owners & Shareholders
Details Hidden

ARK Investment Management is a registered investment adviser and privately held investment firm, specializing in thematic investing. The firm is rooted in over thirty years of experience in identifying and investing in disruptive innovations that enable outsized growth as industries transform. Through its open source research process, ARK is able to identify companies that it believes are leading and benefiting from disruptive cross-sector forces and changing how the world works.

Details Hidden

BBA pursues a fundamentally-driven approach to life sciences investing. The firm typically takes large, concentrated positions in the securities of life sciences companies with the potential for significant value creation over the long-term. They focus on public securities, but may, from time to time, recommend investments in private companies, life sciences and related healthcare intellectual property, royalty streams or other non-public investment opportunities.

Details Hidden

Nikko AMA offers both active and passive investment capabilities across equity, fixed income and alternative asset classes, with key strengths in multiple-pan-Asian asset strategies. Equity analysts are assigned responsibilities based on geographic regions, sectors or investment styles. The firm’s general approach focuses on fundamental bottom-up analysis; although it will vary depending on specific requirements of the investment strategy pursued and is tailored accordingly. Nikko AMA also provides broad coverage of global fixed income markets and currencies with consideration to the following factors: Macro Fundamentals, Interest Rates, Market Liquidity, and Investor Positioning/Relative Performance.

Recent Transactions
Details Hidden

Invitae Corp. purchases Reference Genomics, Inc.

Details Hidden

Invitae Corp. issued USD Common Stock

Details Hidden

Invitae Corp. purchases ArcherDX LLC

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Legal Advisor

Advised onInvitae Corp. issued USD Common Stock

Underwriter

Advised onInvitae Corp. issued USD Common Stock

Escrow Agent

Advised onInvitae Corp. issued USD Common Stock

Underwriter

Advised onInvitae Corp. issued USD Common Stock

Legal Advisor

Advised onInvitae Corp. purchases CombiMatrix Corp.

Managing Director, Health Care Investment Banking Group

Advised onInvitae Corp. issued USD Common Stock

Advisors & Consultants
Legal Advisor

Partner, San Diego at Cooley LLP

Clients

Progyny, Inc. is a fertility benefits management company. It provides fertility solutions to employers, managing IUI, in vitro fertilization (IVF), egg freezing, and other fertility treatments. The company operates through one segment: fertility and pharmacy benefits solutions. It also delivers treatment services and access to the firm’s network of fertility specialist. The company was founded on April 3, 2008 and is headquartered in New York, NY.

Food Allergy Research & Education, Inc. operates as a non-profit organization that provides food allergy research services. It offers programs and advocacy about food allergy awareness. It also provides information and performs fund-raising for research. The company was founded in 2012 and is headquartered in McLean, VA.

The Government of the United States of America is the federal government of the republic of fifty states that constitute the United States, as well as one capital district, and several other territories. The federal government is composed of three distinct branches: legislative, executive and judicial, whose powers are vested by the U.S. Constitution in the Congress, the President, and the federal courts, including the Supreme Court, respectively.

Key Stats and Financials As of 2020
Market Capitalization
$6.55B
Total Enterprise Value
$5.72B
Earnings Per Share
$-4.47
Net Profit
$-602M
EBITDA
$-592M
EBITDAMargin
-211.9%
Total Debt
$450M
Total Equity
$1.98B
Enterprise Value / Sales
20.47x
TEVNet Income
-9.5x
Debt TEV
0.08x
Revenue
$280M
Three Year Compounded Annual Growth Rate Of Revenue
60.03%
Non-Profit Donations & Grants
Investors
Details Hidden

BBA pursues a fundamentally-driven approach to life sciences investing. The firm typically takes large, concentrated positions in the securities of life sciences companies with the potential for significant value creation over the long-term. They focus on public securities, but may, from time to time, recommend investments in private companies, life sciences and related healthcare intellectual property, royalty streams or other non-public investment opportunities.

Details Hidden

Redmill invests in US and non-US healthcare companies. They may also invest in fields related to healthcare where due diligence shows those healthcare assets are the driving force behind value creation and in other sectors from time to time. The firm uses the fundamental research as part of their investment process. Their protocols include company financial models, market models, investment theses, and regular dialogue. Redmill’s sources include contacts with physicians, focus outside US, dialogue with companies, attendance at medical conferences; meetings with private companies, and regular dialogue within the team.

Details Hidden

Rock Springs’ funds aims to generate capital appreciation through investments in a combination of public and private securities of companies in healthcare and healthcare-related industries. The funds focus mostly on public equities, utilizing a long-term, research-intensive approach to investing in healthcare and healthcare-related industries, with a particular emphasis on those companies and/or products that Rock Springs believes serve critical unmet needs.

Suppliers
Roche Holding AG Hospitals & Patient Services | Basel, Switzerland

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

Illumina, Inc. Hospitals & Patient Services | San Diego, CA

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Qiagen N.V. Hospitals & Patient Services | Venlo, Netherlands

QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.

Competitors
Thermo Fisher Scientific, Inc. Industrial Machinery & Manufacturing - Waltham, Massachusetts

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines, as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory on the production line and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

OPKO Health, Inc. Pharmaceuticals - Miami, FL

OPKO Health, Inc., is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment include clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes comprises pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Fulgent Genetics, Inc. Medical Support Services - Temple City, CA

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded on May 13, 2016 and is headquartered in Temple City, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Invitae Corp.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Invitae Corp.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Invitae Corp..